HER2-ResNet: A HER2 classification method based on deep residual network

Technol Health Care. 2022;30(S1):215-224. doi: 10.3233/THC-228020.

Abstract

Background: HER2 gene expression is one of the main reference indicators for breast cancer detection and treatment, and it is also an important target for tumor targeted therapy drug selection. Therefore, the correct detection and evaluation of HER2 gene expression has important value for clinical treatment of breast cancer.

Objective: The study goal is to better classify HER2 images.

Methods: For general convolution neural network, with the increase of network layers, over fitting phenomenon is often very serious, which requires setting the value of random descent ratio, and parameter adjustment is often time-consuming and laborious, so this paper uses residual network, with the increase of network layer, the accuracy will not be reduced.

Results: In this paper, a HER2 image classification algorithm based on improved residual network is proposed. Experimental results show that the proposed HER2 network has high accuracy in breast cancer assessment.

Conclusion: Taking HER2 images in Stanford University database as experimental data, the accuracy of HER2 image automatic classification is improved through experiments. This method will help to reduce the detection intensity and improve the accuracy of HER2 image classification.

Keywords: Breast cancer; HER2; classification; deep neural network; residual network.

MeSH terms

  • Algorithms
  • Breast Neoplasms* / diagnostic imaging
  • Breast Neoplasms* / pathology
  • Disease Progression
  • Female
  • Humans
  • Neural Networks, Computer*